|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2019 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III, JD |
Date | 7/19/2019 1:30:04 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 3502, Protecting People From Surprise Medical Bills Act, all provisions
H.R. 2569, Comprehensive Addiction Resources Emergency Act of 2019, all provisions
H.R. 2279, Safe Step Act, all provisions
S. 1895, Lower Health Care Costs Act, all provisions
H.R. 1010, To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect, all provisions
H.R. 2862, Vaccine Awareness Campaign to Champion Immunization Nationally and Enhance Safety (VACCINES) Act of 2019, all provisions
S. 2032, Cannabidiol and Marihuana Research Expansion Act, all provisions
H.R. 5, Equality Act, all provisions
H.R. 3630, No Surprises Act, all provisions
21st Century Cures Act
Affordable Care Act (ACA) stabilization
Title X
Mothers and Offspring Mortality and Morbidity Awareness (MOMMA) Act
Stopping the Outrageous Practice of Surprise Medical Bills Act
Drug Pricing
Health care augmented intelligence
Maternal mortality and health care disparity
Opioids/Substance use disorder
Prior authorization
Telehealth
Surprise Billing
Open Payments/Sunshine Act
Physician self-employment
Physician-assisted Suicide
Health IT - Patient privacy, 42 CFR Part 2, HIPAA
Health IT - Interoperability
EHR - Data blocking
EHR measure specifications
EHR Certification
Gun violence
Medical marijuana research
Standardization of food date labelling practices
EPA Development of water quality testing/schools and childcare facilities
Food Insecurity
Accountable Care Organizations
In-office Compounding
Digital Medicine
Health Care Costs/Transparency/Reduction
Pain management
Consumer Privacy
Sequoia Project
Trusted Exchange Framework/Common Agreement
E-cigarette components packaging labels
Cybersecurity
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), Environmental Protection Agency (EPA), Agriculture - Dept of (USDA), Health & Human Services - Dept of (HHS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), White House Office, Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Jennifer |
McLaughlin |
|
|
|
Matthew |
Reid |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Debra |
Cohn |
|
|
|
Sylvia |
Trujillo |
|
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R. 3239, Humanitarian Standards for Individuals in Customs and Border Protection Custody Act, all provisions
H.R. 2895, Conrad State 30 and Physician Access Reauthorization Act, all provisions
S. 948, Conrad State 30 and Physician Access Reauthorization Act, all provisions
Immigration
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Homeland Security - Dept of (DHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Competition in the health insurance industry
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Chase |
Thomas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 2569, Comprehensive Addiction Resources Emergency Act of 2019, provisions relating to Medicaid
H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act, all provisions
H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019, all provisions
H.R. 2282, Medicare Care Coordination Improvement Act of 2019, all provisions
H.R. 2143, Promoting Integrity in Medicare Act (PIMA) of 2019, all provisions
H.R. 1358, Advancing Medical Resident Training in Community Hospitals Act of 2019, all provisions
H.R. 1763, Resident Physician Shortage Reduction Act of 2019, all provisions
S. 348, Resident Physician Shortage Reduction Act of 2019, all provisions
H.R. 3302, Keep Physicians Serving Patients Act of 2019, all provisions
H.R. 2439, Opioid Workforce Act of 2019, all provisions
Medicare program: Drug Pricing
Medicare program: Regulatory Relief
Medicare program: Medicare for All
Medicare program: Medicare coverage
Medicare program: Physician self-referral and Civil Monetary Penalties Laws
Medicare program: Fraud and Abuse
Medicare program: Medicare Part D
Medicare program: Pharmacy Benefits Manager (PBM)/Rx drug price transparency
Medicare program: Physician payment and delivery reform
Medicare program: Quality Payment Program
Medicare program: Merit-Based Incentive Payment System (MIPS)
Medicare program: Alternative Payment Models (APMs)/ Physician-Focused Payment Model Technical Advisory Committee (PTAC)
Medicare program: MACRA cost measure development
Medicare program: Inpatient Prospective Payment System (IPPS)
Medicare program: Accountable Care Organizations
Medicare program: Evaluation and Management codes and payment policies
Medicare program: Digital Medicine
Medicare program: Diabetes Prevention Program
Medicare program: Ambulatory blood pressure monitoring
Medicare program: Open Payments/Sunshine Act
Medicare program: Provider compliance
Medicare program: Provider Enrollment, Chain, and Ownership System (PECOS) Enrollment
Medicare program: Quality Payment Program (QPP)
Medicare and Medicaid programs: Medicare Access and CHIP Reauthorization Act (MACRA) implementation
Medicare and Medicaid programs: Opioids/Substance use disorder
Medicare and Medicaid programs: Telehealth
Medicare and Medicaid programs: 21st Century Cures Act
Medicare and Medicaid programs: Data blocking/Interoperability/patient access
Medicare and Medicaid programs: Health IT burden
Medicare and Medicaid programs: Pain management
Medicare and Medicaid programs: Cybersecurity
Medicaid program: Section 1115 Demonstration Waivers
17. House(s) of Congress and Federal agencies Check if None
Centers For Medicare and Medicaid Services (CMS), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Jennifer |
McLaughlin |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Debra |
Cohn |
|
|
|
Sylvia |
Trujillo |
|
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
VA MISSION Act of 2018 implementation
VA Choice/Community Care Program
Scope of Practice
Tricare Access
Uniformed medical position reductions/data transparency
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA), Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Youth and flavored tobacco products/cigars/e-cigarettes
17. House(s) of Congress and Federal agencies Check if None
Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
EDU |
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |